Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 107 (Search time: 0.014 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Cetuximab for the treatment of colorectal cancerJonker, D.; O'Callaghan, C.; Karapetis, C.; Zalcberg, J.; Tu, D.; Au, H.; Berry, S.; Krahn, M.; Price, T.; Simes, R.; Tebbutt, N.; van Hazel, G.; Wierzbicki, R.; Langer, C.; Moore, M.
2013Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival?Broadbridge, V.; Karapetis, C.; Beeke, C.; Woodman, R.; Padbury, R.; Maddern, G.; Kim, W.; Roder, D.; Hakendorf, P.; Price, T.
2011South Australian clinical registry for metastatic colorectal cancerNeo, E.; Beeke, C.; Price, T.; Maddern, G.; Karapetis, C.; Luke, C.; Roder, D.; Padbury, R.
2011Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerHaller, D.; Tabernero, J.; Maroun, J.; de Braud, F.; Price, T.; Van Cutsem, E.; Hill, M.; Gilberg, F.; Rittweger, K.; Schmoll, H.
2016Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancerTie, J.; Wang, Y.; Tomasetti, C.; Li, L.; Springer, S.; Kinde, I.; Silliman, N.; Tacey, M.; Wong, H.; Christie, M.; Kosmider, S.; Skinner, I.; Wong, R.; Steel, M.; Tran, B.; Desai, J.; Jones, I.; Haydon, A.; Hayes, T.; Price, T.; et al.
2007Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1 864 patientsSchmoll, H.; Cartwright, T.; Tabernero, J.; Nowacki, M.; Figer, A.; Maroun, J.; Price, T.; Lim, R.; Van Custem, E.; Park, Y.; McKendrick, J.; Topham, C.; Soler-Gonzalez, G.; de Braud, F.; Hill, M.; Sirzen, F.; Haller, D.
2014Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignanciesPatel, G.; Jain, K.; Kumar, R.; Strickland, A.; Pellegrini, L.; Slavotinek, J.; Eaton, M.; McLeay, W.; Price, T.; Ullah, S.; Koczwara, B.; Kichenadasse, G.; Karapetis, C.
2012ESMO consensus guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision makingPrice, T.
2016Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerSchofield, P.; Stockler, M.; Zannino, D.; Tebbutt, N.; Price, T.; Simes, R.; Wong, N.; Pavlakis, N.; Ransom, D.; Moylan, E.; Underhill, C.; Wyld, D.; Burns, I.; Ward, R.; Wilcken, N.; Jefford, M.
2012Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancerKhattak, M.; Martin, H.; Beeke, C.; Price, T.; Carruthers, S.; Kim, S.; Padbury, R.; Karapetis, C.